Aeolus Pharmaceuticals, Inc.'s ticker is AOLS and the CUSIP is 00765G109. A total of 1 filers reported holding Aeolus Pharmaceuticals, Inc. in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $6,000 | -25.0% | 22,521 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $8,000 | +33.3% | 22,521 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $6,000 | +20.0% | 22,521 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $5,000 | -16.7% | 22,521 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $6,000 | -14.3% | 22,521 | 0.0% | 0.00% | -50.0% |
| Q2 2013 | $7,000 | – | 22,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAMILTON LANE ADVISORS LLC | 22,521 | $6,000 | 0.00% |